|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 33/26 | |
| A61K 31/655 | |||
| A61P 1/06 | |||
| A61P 1/00 |
| (11) | Patento numeris | 2563117 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11775497.8 |
| Europos patento paraiškos padavimo data | 2011-04-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/033905 |
| Data | 2011-04-26 |
| (87) | Numeris | WO 2011/137103 |
| Data | 2011-11-03 |
| (30) | Numeris | Data | Šalis |
| 328151 P | 2010-04-26 | US |
| (72) |
FORBES, William, US
BORTEY, Enoch, US
JOHNSON, Lorin, US
|
| (73) |
Salix Pharmaceuticals, Ltd.,
8510 Colonnade Center Drive, Raleigh, NC 27615,
US
|
| (54) | FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES |
| FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES |